| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $49.8M | +41.7% |
| SG&A Expense | $35.1M | +53.2% |
| Operating Income | -$84.9M | -46.3% |
| Pre-tax Income | -$81.4M | -39.3% |
| Income Tax | $0 | +100.0% |
| Net Income | -$81.4M | -39.4% |
| EPS (Basic) | -$0.38 | -26.7% |
| EPS (Diluted) | -$0.38 | -26.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $77.6M | -18.3% |
| Current Assets | $98.5M | -4.0% |
| Total Assets | $108.6M | +2.7% |
| Current Liabilities | $18.5M | +163.7% |
| Long-term Debt | $2.3M | +33.7% |
| Total Liabilities | $24.6M | +147.2% |
| Stockholders' Equity | $84.1M | -12.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$60.1M | -25.3% |
| Capital Expenditures | $4.5M | +374.7% |
| Investing Cash Flow | -$17.0M | -834.3% |
| Financing Cash Flow | $59.5M | -50.7% |
| Free Cash Flow | -$64.5M | -32.0% |